[First clinical observations on the antituberculous activity of a compound derived from the salification of streptomycin and Congo red].
D000814:Aniline Compounds / Q000627:therapeutic use*; D004396:Coloring Agents / Q000627:therapeutic use*; D003224:Congo Red; D006801:Humans; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014390:Tuberculosis, Meningeal / Q000628:therapy*; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D000814:Aniline Compounds; D004396:Coloring Agents; D003224:Congo Red; C023650:aniline; D013307:Streptomycin
ANILINE DYES/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, MENINGEAL/therapy; TUBERCULOSIS, PULMONARY/therapy
Prime osservazioni cliniche sull'attività anti-tubercolare d'un composto derivante dalla salificazione della streptomicina con il rosso Congo.